UroGen Pharma Ltd. (URGN) |
|
37.74 -1.61 (-4.09%)
|
05-22 16:00 |
|
Open: |
39.38 |
Pre. Close: |
39.35 |
|
High:
|
39.88 |
Low:
|
37.73 |
|
Volume:
|
112,157 |
Market Cap:
|
785M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
39.993 - 40.214 |
40.214 - 40.394 |
|
Low:
|
37.065 - 37.369 |
37.369 - 37.617 |
|
Close:
|
37.295 - 37.744 |
37.744 - 38.109 |
|
|
|
Technical analysis |
as of: 2019-05-22 4:27:44 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 44.70 One year: 46.68 |
| Support: |
Support1: 35.52 Support2: 29.55 |
| Resistance: |
Resistance1: 38.27 Resistance2: 39.97 |
| Pivot: |
38.05 |
| Moving Average: |
MA(5): 38.32 MA(20): 37.79 
MA(100): 40.52 MA(250): 44.76 |
| MACD: |
MACD(12,26): 0.17 Signal(9): 0.11 |
| Stochastic oscillator: |
%K(14,3): 57.14 %D(3): 59.62 |
| RSI: |
RSI(14): 48.79 |
| 52-week: |
High: 62.69 Low: 34.61 Change(%): -38.6 |
| Average Vol(K): |
3-Month: 12770 10-Days: 17019 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.URGN has closed above bottom band by 41.8%. Bollinger Bands are 47.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to URGN's normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 20 May 2019 18:08:49 Z
These 3 Small-Cap Healthcare Stocks Reported Big Updates This Month
Thu, 09 May 2019 18:58:04 Z
UroGen Pharma Ltd. (URGN) Q1 2019 Earnings Call Transcript
Sun, 21 Apr 2019 00:07:03 Z
3 International Companies Making Waves in the U.S. Soon
Tue, 16 Apr 2019 16:10:17 Z
1 Under-the-Radar Healthcare Stock Wall Street is Overlooking
Thu, 28 Feb 2019 18:11:03 Z
UroGen Pharma Ltd. (URGN) Q4 2018 Earnings Conference Call Transcript
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
